Richard Glickman

Richard Glickman is a declared insider of ESSA Pharma Inc., with filings sourced from SEC (Form 4). In total, 6 filings cover trades dated from 25 April 2018 to 24 April 2024.

Purchases make up the whole of the open-market record (3 purchases, €32k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 option exercise.

Half of the purchases are above €6,149 and half below.

Most recently, on 24 April 2024, the filings show an option exercise worth €13k in ESSA Pharma Inc. The latest purchase dates back some time: it was published 2,238 days ago, on 24 September 2020. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.